23 March 2018
For Russian pharmaceutical manufacturers, the overall results of 2017 were not impressive at all, to put it mildly. In total, last year, Russia manufactured about 4.5 billion packages of medicinal products, which is only 0.7% more than for 2016. The ruble-denominated figure for the same period looks better reaching 6.1%. However, it is still not even close to the pace demonstrated by the Russian pharmaceutical industry in 2015-2016.
Overall, in 2017, the pharmaceutical companies released into circulation the medicinal products worth 333.6 billion rubles (ex warehouse prices, including VAT).
In December 2017, Russian pharmaceutical manufacturers shipped the medicinal products worth 31.6 billion rubles (ex warehouse prices including VAT). The long-term dynamics reached 7% (in rubles terms). However, the performance in the last month of 2017 was definitely not outstanding, whether in terms of volume or in terms of dynamic indicators, because in January, March, and August 2017, the industry was growing in double-digit figures. In December 2017, the physical volume of shipped products reached an impressive level of 0.41 billion packages. Last year, a better performance was reported only in March (0.42 billion packages). However, in physical terms, the dynamics was still negative compared to December 2016 (-5.4%).
In December 2017, the absolute leader in terms of physical volume growth among Top 20 brands was Venarus (manufactured by OBL Pharm), as the shipments of this drug over the year increased by 41.6 times.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024